FLX 787Alternative Names: FLX-788; FLX-797; FLX-798; FLX787; TRP activators - Flex Pharma; TRPA1 activators - Flex Pharma; TRPV1 activators - Flex Pharma
Latest Information Update: 09 Feb 2017
At a glance
- Originator Flex Pharma
- Mechanism of Action TRPA1 protein stimulants; TRPV cation channel agonists; TRPV1 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Amyotrophic lateral sclerosis; Multiple sclerosis
- Phase I Motor neuron disease
- Preclinical Neuromuscular disorders